Search form
Using a standard catheter, the MicroEYE™ allows continuous, automated and real-time blood sampling in a 48-hour period without leaving the patient.

Probe is developing its first sales of MicroEye® in the exciting clinical research markets in Europe, while continuing development of other devices and systems for the intensive/critical care markets. Probe has started the registration process with The FDA for the USA market.